Disease site number was not prognostic in a low-risk Hodgkin lymphoma combined modality trial: revisiting PHC HOD90.

Feraco, Angela M; Zhou, Yiwang; Zheng, Ying; Marks, Lianna J; Friedmann, Alison; Weinstein, Howard J; Link, Michael P; Flerlage, Jamie E

Feraco, Angela M; Zhou, Yiwang; Zheng, Ying; Marks, Lianna J; Friedmann, Alison; Weinstein, Howard J; Link, Michael P; Flerlage, Jamie E.

Affiliation

Feraco AM; Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA.
Zhou Y; Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, TN.
Zheng Y; Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, TN.
Marks LJ; Stanford Children's Health, Stanford University, Stanford, CA.
Friedmann A; Pediatric Hematology/Oncology, Massachusetts General Hospital for Children, Boston, MA.
Weinstein HJ; Pediatric Hematology/Oncology, Massachusetts General Hospital for Children, Boston, MA.
Link MP; Stanford Children's Health, Stanford University, Stanford, CA.
Flerlage JE; Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN.

Blood Adv ; 7(21): 6665-6667, 2023 11 14.

Article de En | MEDLINE | ID: mdl-37647596

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Lymphome malin non hodgkinien / Maladie de Hodgkin Type d'étude: Etiology_studies / Prognostic_studies / Risk_factors_studies Limites: Humans Langue: En Journal: Blood Adv Année: 2023 Type de document: Article Pays d'affiliation: Maroc Pays de publication: États-Unis d'Amérique

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google